Torcetrapib

An investigation is underway as to whether Pfizer was prompt in its cancellation of clinical trials for Torcetrapib, their new drug focused on promoting good cholesterol.

The death rate in the clinical trial was unacceptable high.

Torcetrapib in the News

Torcetrapib Death Rate

If a you or a loved one experienced heart problems, or a loved one died while participating in a Torcetrapib clinical trial, you may be eligible for compensation. Please contact a Torcetrapib lawyer by clicking the link below, for a free case evaluation.
Published on Dec-3-06